Cite
HARVARD Citation
Wang, M. et al. (2019). Delanzomib, a novel proteasome inhibitor, sensitizes breast cancer cells to doxorubicin‐induced apoptosis. Thoracic cancer. 10 (4), pp. 918-929. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, M. et al. (2019). Delanzomib, a novel proteasome inhibitor, sensitizes breast cancer cells to doxorubicin‐induced apoptosis. Thoracic cancer. 10 (4), pp. 918-929. [Online].